Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects of Tebapivat and AG-946 in Patients with Sickle Cell Disease
FranceComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
FranceClinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments
FranceStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
FranceStudy on Ersodetug for Patients with Uncontrolled Low Blood Sugar Due to Tumor-Related High Insulin Levels
FranceEvaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia
FranceStudy on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)
FranceStudy on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema
FranceStudy on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis
FranceStudy of pucotenlimab with becotatug vedotin versus becotatug vedotin alone for patients with locally advanced head and neck squamous cell carcinoma
FranceStudy on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy
FranceStudy of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
